News Digest / Income Statements / Westlake Chemical Reports Major Revenue and Income Declines Amid Operational Challenges

Westlake Chemical Reports Major Revenue and Income Declines Amid Operational Challenges

StockInvest.us
04:02pm, Friday, May 02, 2025
Illustration by StockInvest.us

Westlake Chemical Partners LP (NYSE: WLKP) released its quarterly financial report for the period ended March 31, 2025. The report highlights a significant decrease in both revenue and net income compared to the previous year, amid operational challenges.

Key Financial Highlights:

  • Net Sales: $237.6 million in Q1 2025, down 16.5% from $284.7 million in Q1 2024.
  • Net Income: $42.3 million in Q1 2025, down 52.8% from $89.6 million in Q1 2024.
  • Income from Operations: $46.6 million in Q1 2025, down 51.0% from $95.1 million in Q1 2024.
  • Net Income Attributable to Partners: $4.9 million in Q1 2025, compared to $14.8 million in Q1 2024.
  • EBITDA: $75 million in Q1 2025, down 39.6% from $124.4 million in Q1 2024.
  • MLP Distributable Cash Flow: $4.7 million, significantly down from $16.9 million last year.

Positive Aspects:

  • Despite the decline in overall sales, the partnership saw an increase in sales prices for ethylene and co-products.
  • Management has effective strategies in place to manage operational costs, particularly in light of the Petro 1 maintenance turnaround.

Negative Aspects:

  • Substantial decrease in production volumes due to the Petro 1 turnaround has heavily impacted sales and net income.
  • Higher costs related to ethane feedstock and natural gas contributed to a significantly lower gross profit margin, dropping from 35.9% in Q1 2024 to 22.8% in Q1 2025.
  • Significant reliance on Westlake Corporation as a major customer, accounting for approximately 80.3% of net sales.

Balance Sheet Summary (As of March 31, 2025):

  • Total Assets: $1.37 billion, an increase from $1.29 billion at year-end 2024.
  • Total Liabilities: $568.2 million, up from $458.6 million at year-end 2024.
  • Equity: $803.1 million, down from $829.3 million at year-end 2024.

Westlake Chemical Partners is currently evaluating potential recovery plans and capital expenditures to enhance future production efficiency. Management's forward-looking statements indicate a proactive approach to navigating upcoming operational challenges and market fluctuations.

About The Author

StockInvest.us

StockInvest.us is a stock market research tool that provides daily stock signals and technical analysis for over 25 000 tickers on 38 exchanges. The company was founded in 2016 in Vilnius, Lithuania.

Trusted Broker
Start Your Journey With:
eToro
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs

Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk.